Nov 25 2022
A new study has found that CBD reduces seizures in patients with Dravet syndrome (SD), Lennox-Gataut syndrome (LGS), or tuberous sclerosis complex (TSC), who are resistant to common medications. Published by the journal Revista da Associação Médica Brasileira and epublished by the National Library of Medicine, the study was conducted by researchers at Medicina Baseada …
Nov 23 2022
New Canada sales data shows that there was $389.9 million in legal marijuana sold in September, a 12% increase from September, 2021. The 389.9 million Canadian dollars ($291 million) worth of legal marijuana sold in September exactly matches the amount of legal marijuana and marijuana products sold in August, according to the national data agency Statistics …
Nov 22 2022
Rhode Island Governor Dan McKee announced this morning that five licensed medical marijuana compassion centers have received state approval to begin selling recreational marijuana on or after December 1. These five outlets will be the first in the state to legally sell recreational marijuana to those 21 and older. The licenses are being issued pursuant …
Nov 21 2022
Oregon Governor Kate Brown announced today that she has issued pardons to everyone caught possessing up to an ounce of marijuana prior to its legalization in 2016. The pardons will remove 47,144 convictions for possession of a small amount of marijuana from individual records, eliminating barriers for thousands of people seeking employment, housing, and educational …
Nov 21 2022
Cannabinoids may induce immunogenic cell death indicating they may be useful in combatting cancer. This is according to a new study being published in the upcoming issue of the peer-reviewed journal Cannabis and Cannabinoids Research. The study was epublished by the National Institute of Health, and “is the first demonstration that cannabinoids can induce the …
Nov 20 2022
Oral cannabinoid therapy seems to be safe and at least mildly effective in patients with treatment refractory chronic pain, according to a new European Journal of Pain study. “Cannabinoids are considered a therapeutic option to patients suffering from treatment refractory chronic pain (TRCP) insufficiently relieved by conventional analgesics or experiencing intolerable adverse events (AEs) from …
Nov 18 2022
On Wednesday the U.S. Senate passed the Medical Marijuana and Cannabidiol Research Expansion Act, making it the first standalone piece of marijuana legislation to ever reach the president’s desk. Now the White House says President Biden will soon sign it into law. H.R. 8454 passed the Senate on Wednesday and passed the House of Representatives …
Nov 18 2022
Cannabidiol (CBD) enriched with terpenes may provide a safe and effective treatment option for autism spectrum disorder and is more effectice than CBD alone. This is according to a case report study being published in the journal Frontiers in Pharmacology and epublished by the U.S. National Library of Medicine. “Cannabidiol (CBD) rich products are successfully …
Nov 17 2022
Legalizing recreational marijuana at the state level doesn’t have a significant impact on crime rates, according to a new study published in the Journal of Drug Issues. For the study researchers affiliated with the University of Colorado and Boise State University compared crime data in Colorado and Washington – the first two states to legalize marijuana …
Nov 16 2022
The Senate today passed the Medical Marijuana and Cannabidiol Research Expansion Act, which would expand research into marijuana-derived medications. H.R. 8454 passed the House of Representatives in July by an overwhelming vote of 325 to 95. The measure now goes to the desk of President Biden, who is expected to quickly sign it into law. …
